Harnessing synthetic biology to develop novel psychedelic therapies
Trends Biotechnol
.
2023 Apr;41(4):586-587.
doi: 10.1016/j.tibtech.2022.12.003.
Epub 2022 Dec 23.
Authors
J Andrew Jones
1
,
Michael G Spigarelli
2
Affiliations
1
PsyBio Therapeutics, Sunrise, FL 33351, USA; Chemical, Paper, and Biomedical Engineering, Miami University, Oxford, OH 45056, USA. Electronic address: jones@miamioh.edu.
2
PsyBio Therapeutics, Sunrise, FL 33351, USA; Department of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA.
PMID:
36567184
DOI:
10.1016/j.tibtech.2022.12.003
No abstract available
MeSH terms
Hallucinogens* / pharmacology
Hallucinogens* / therapeutic use
Synthetic Biology
Substances
Hallucinogens